Chronic Coronary Artery Lesions: Advanced Diagnostic Modalities and Therapeutic Strategies with Emphasis on Intravascular Ultrasound and Optical Coherence Tomography
Main Article Content
Abstract
Chronic coronary artery lesions represent a complex and progressive manifestation of atherosclerotic disease, often leading to significant morbidity and mortality due to myocardial ischemia and subsequent adverse cardiovascular events. The accurate diagnosis and characterization of these lesions are paramount in guiding optimal therapeutic interventions and improving long-term prognostic outcomes. In contemporary interventional cardiology, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have emerged as indispensable imaging modalities, offering high-resolution, cross-sectional visualization of coronary artery architecture, plaque composition, and vessel dimensions. These advanced techniques facilitate precise lesion assessment, enabling tailored revascularization strategies, including percutaneous coronary intervention (PCI) with stent optimization. This article comprehensively reviews the pathophysiology of chronic coronary lesions, current evidence-based treatment approaches, and the prognostic implications of various therapeutic modalities. Furthermore, it highlights the pivotal role of IVUS and OCT in enhancing diagnostic accuracy, procedural success, and long-term vessel patency, thereby refining clinical decision-making in the management of chronic coronary artery disease.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. P. Mincarone, A. Bodini, M.R. Tumolo, et al. Discrimination capability of pretest probability of stable coronary artery disease: a systematic review and meta-analysis suggesting how to improve validation procedures BMJ Open, 11 (2021), Article e047677
II. S. Feger, P. Ibes, A.E. Napp, et al. Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study Eur Radiol, 31 (2021), pp. 1471-1481
III. S. Winther, S.E. Schmidt, T. Mayrhofer, et al. Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease J Am Coll Cardiol, 76 (2020), pp. 2421-2432
IV. V.Y. Cheng, D.S. Berman, A. Rozanski, et al. Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiographically significant coronary artery disease in patients undergoing coronary computed tomographic angiography: results from the multinational coronary CT angiography evaluation for clinical outcomes: an international multicenter registry (CONFIRM) Circulation, 124 (2011), pp. 2423-2432
V. U. Hoffmann, M. Ferencik, J.E. Udelson, et al. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Circulation, 135 (2017), pp. 2320-2332
VI. J. Reeh, C.B. Therming, M. Heitmann, et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J, 40 (2019), pp. 1426-1435
VII. J. Knuuti, W. Wijns, A. Saraste, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J, 41 (2020), pp. 407-477
VIII. M. Gulati, P.D. Levy, D. Mukherjee, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines J Am Coll Cardiol, 78 (22) (2021), pp. e187-e285
IX. M. Lui, S. Safiri, A. Mereke, et al. Burden of ischemic heart disease in Central Asian countries, 1990-2017. Int J Cardiol Heart Vasc, 33 (2021), Article 100726
X. M. Nair, D. Prabhakaran Why do South Asians have high risk for CAD? Glob Heart, 7 (2012), pp. 307-314
XI. H. Dai, A.A. Much, E. Maor, et al. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes, 8 (2022), pp. 50-60
XII. D. Zhao Epidemiological features of cardiovascular disease in Asia JACC: Asia, 1 (2021), pp. 1-13
XIII. Institute for Health Metrics and Evaluation GBD results http://ghdx.healthdata.org/gbd-results-tool, Accessed 29th juli 2025
XIV. H. Iso Cardiovascular disease, a major global burden: epidemiology of stroke and ischemic heart disease in Japan Glob Health Med, 3 (2021), pp. 358-364
XV. S. Yusuf, S. Reddy, S. Ounpuu, S. Anand Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation, 104 (2001), pp. 2746-2753